Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferran Nadeu

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Cells|November 27, 2024
Association of Genomic Alterations with the Presence of Serum Monoclonal Proteins in Chronic Lymphocytic LeukemiaJuan A Piñeyroa, Irene López-Oreja, Ferran Nadeu, et al.
British Journal of Haematology|December 6, 2018
Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab eraAlfredo Rivas-Delgado, Laura Magnano, Miriam Moreno-Velázquez, et al.
Hematological Oncology|May 25, 2022
Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemiaJuan A Piñeyroa, Laura Magnano, Andrea Rivero, et al.
The American Journal of Surgical Pathology|October 2, 2015
NOTCH1, TP53, and MAP2K1 Mutations in Splenic Diffuse Red Pulp Small B-cell Lymphoma Are Associated With Progressive DiseaseDaniel Martinez, Alba Navarro, Alejandra Martinez-Trillos, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 13, 2018
A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberrationGrzegorz Rymkiewicz, Beata Grygalewicz, Magdalena Chechlinska, et al.
Blood|September 6, 2018
Altered patterns of global protein synthesis and translational fidelity in RPS15-mutated chronic lymphocytic leukemiaGabriel Bretones, Miguel G Álvarez, Javier R Arango, et al.
Blood|June 30, 2021
The protein landscape of chronic lymphocytic leukemiaFabienne Meier-Abt, Junyan Lu, Ester Cannizzaro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2020
A Cyclin D1-Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell LymphomaSantiago Demajo, Robert Albero, Guillem Clot, et al.
Frontiers in Immunology|July 16, 2025
Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond <i>MYD88</i> L265PDavid F Moreno, Ferran Nadeu, Fara Brasó-Maristany, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2020
The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease OutcomeChristian Brieghel, Caspar da Cunha-Bang, Christina Westmose Yde, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Cells|November 27, 2024
Association of Genomic Alterations with the Presence of Serum Monoclonal Proteins in Chronic Lymphocytic LeukemiaJuan A Piñeyroa, Irene López-Oreja, Ferran Nadeu, et al.
British Journal of Haematology|December 6, 2018
Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab eraAlfredo Rivas-Delgado, Laura Magnano, Miriam Moreno-Velázquez, et al.
Hematological Oncology|May 25, 2022
Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemiaJuan A Piñeyroa, Laura Magnano, Andrea Rivero, et al.
The American Journal of Surgical Pathology|October 2, 2015
NOTCH1, TP53, and MAP2K1 Mutations in Splenic Diffuse Red Pulp Small B-cell Lymphoma Are Associated With Progressive DiseaseDaniel Martinez, Alba Navarro, Alejandra Martinez-Trillos, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 13, 2018
A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberrationGrzegorz Rymkiewicz, Beata Grygalewicz, Magdalena Chechlinska, et al.
Blood|September 6, 2018
Altered patterns of global protein synthesis and translational fidelity in RPS15-mutated chronic lymphocytic leukemiaGabriel Bretones, Miguel G Álvarez, Javier R Arango, et al.
Blood|June 30, 2021
The protein landscape of chronic lymphocytic leukemiaFabienne Meier-Abt, Junyan Lu, Ester Cannizzaro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2020
A Cyclin D1-Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell LymphomaSantiago Demajo, Robert Albero, Guillem Clot, et al.
Frontiers in Immunology|July 16, 2025
Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond <i>MYD88</i> L265PDavid F Moreno, Ferran Nadeu, Fara Brasó-Maristany, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2020
The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease OutcomeChristian Brieghel, Caspar da Cunha-Bang, Christina Westmose Yde, et al.
Pageof 9